Full-length MSP1/GLA-SE (SUM-101) Malaria Vaccine(European Vaccine Initiative)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameFull-length MSP1/GLA-SE (SUM-101) Malaria Vaccine(European Vaccine Initiative)
Drug Alias NameSUM-101(European Vaccine Initiative)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBurkina Faso
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEuropean Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesEuropean Vaccine Initiative
Inactive CompaniesN/A
Active IndicationsMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A